Items where Author is "Entwisle, C"

Journal article

AHMAD, M., REES, R.C., MCARDLE, S.E., LI, G., MIAN, S., ENTWISLE, C., LOUDON, P. and ALI, S.A., 2005. Regulation of CTL responses to MHC-restricted class I peptide of the gp70 tumour antigen by splenic parenchymal CD4(+) T cells in mice failing immunotherapy with DISC-mGM-CSF. International Journal of Cancer, 115 (6), pp. 951-959. ISSN 0020-7136

ALI, S.A., AHMAD, M., LYNAM, J., MCLEAN, C.S., ENTWISLE, C., LOUDON, P., CHOOLUN, E., MCARDLE, S.E., LI, G., MIAN, S. and REES, R.C., 2004. Anti-tumour therapeutic efficacy of OX40L in murine tumour model. Vaccine, 22 (2728), pp. 3585-3594. ISSN 0264-410X

ALI, S.A., LYNAM, J., MCLEAN, C.S., ENTWISLE, C., LOUDON, P., ROJAS, J.M., MCARDLE, S.E., LI, G., MIAN, S. and REES, R.C., 2002. Tumor regression induced by intratumor therapy with a disabled infectious single cycle (DISC) herpes simplex virus (HSV) vector, DISC/HSV/murine granulocyte-macrophage colony-stimulating factor, correlates with antigen-specific adaptive immunity. Journal of Immunology, 168 (7), pp. 3512-3519. ISSN 0022-1767

LOUDON, P.T., CHOOLUN, E., CURRY, J., DAY, D.A., DUNCAN, I.A., ENTWISLE, C., LOWDEN, R.C., MCLEAN, C.S., MARTIN, G., SHAW, M.L., GORE, M., HARRIS, A.L., ALI, S.A., LYNAM, J. and REES, R.C., 2001. Phase I clinical trial of DISC-GMCSF for immunotherapy of metastatic melanoma. Cancer Gene Therapy, 8. ISSN 0929-1903

ALI, S.A., MCLEAN, C.S., BOURSNELL, M.E.G., MARTIN, G., HOLMES, C.L., REEDER, S., ENTWISLE, C., BLAKELEY, D.M., SHIELDS, J.G., TODRYK, S., VILE, R., ROBINS, R.A. and REES, R.C., 2000. Preclinical evaluation of 'whole' cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes. Cancer Research, 60 (6), pp. 1663-1670. ISSN 0008-5472

BOURSNELL, M.E.G., ENTWISLE, C., ALI, S.A., SIVASUBRAMANIAM, S.D., REEDER, S., MCLEAN, C.S., BLAKELEY, D.M., MILLER, J., HILL, S., SHIELDS, J.G., INGLIS, S.C. and REES, R.C., 1998. Disabled infectious single cycle (DISC) herpes simplex virus as a vector for immunotherapy of cancer. Gene Therapy of Cancer, 451, pp. 379-384. ISSN 0065-2598

BOURSNELL, M.E.G., ENTWISLE, C., ALI, S.A., SIVASUBRAMANIAM, S.D., REEDER, S., MCLEAN, C.S., BLAKELEY, D.M., SHIELDS, J.G., INGLIS, S.C. and REES, R.C., 1997. Disabled infectious single cycle (DISC) herpes simplex virus as a vector for immunotherapy of cancer. Cancer Gene Therapy, 4 (5), p. 321. ISSN 0929-1903